After graduating from a Bachelor of Pharmaceutical Science, Ashlyn decided to pursue her honours year with the ACTB group, under the supervision of A/Prof. Anton Blencowe. Her research focuses on the development of electrostatically controlled drug release of alendronate from molecularly imprinted polymer, intended for future loading in biodegradable implants for the treatment of osteoporosis.
Outside of research, Ashlyn has been involved in practical demonstrating for undergraduate chemistry courses, Chemistry 100 and Chemistry 101.
About me
After graduating from a Bachelor of Pharmaceutical Science, Ashlyn decided to pursue her honours year with the ACTB group, under the supervision of A/Prof. Anton Blencowe. Her research focuses on the development of electrostatically controlled drug release of alendronate from molecularly imprinted polymer, intended for future loading in biodegradable implants for the treatment of osteoporosis.
Outside of research, Ashlyn has been involved in practical demonstrating for undergraduate chemistry courses, Chemistry 100 and Chemistry 101.
Research
Research outputs for the last seven years are shown below. To see earlier years visit ORCID
Open access indicates that an output is open access.
| Year | Output |
|---|---|
| 2022 |
Open access
5
|
External engagement & recognition
| Organisation | Country |
|---|---|
| Australian Nuclear Science and Technology Organisation | AUSTRALIA |
| University of South Australia | AUSTRALIA |
Teaching & student supervision
